US-listed company LIXTE Biotechnology launches crypto reserve strategy, plans to allocate 25% of funds to BTC

Bitget App

Trade smarter

Bitget

News

Chaincatcher2025/08/13 12:07

Show original

According to ChainCatcher, Nasdaq-listed company LIXTE Biotechnology has announced that its board of directors has approved a strategic capital allocation plan to acquire cryptocurrencies as part of the company’s funds. The board has also approved allocating 25% of its funds to cryptocurrencies, including Bitcoin and potentially other digital assets as appropriate.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PoolX: Earn new token airdrops

Lock your assets and earn 10%+ APR

Lock now!

Trending news

Milan: Policy Views Differ on the Pace of Rate Cuts and Final Targets

Glassnode: Continued market weakness would be a key warning signal of structural deterioration; recent pullbacks are mainly due to localized deleveraging rather than large-scale capital outflows.